2020 GMS5104 Biotherapeutics and Biosimilars

The advent of biotherapeutics and biosimilars highlighted the need for regulatory affairs to accommodate the evolving medical sciences, necessitating timely revisions in policies, processes and the technical knowledge in managing these new innovations and facilitating access to meet medical needs. This course provides the background to the rise of these biologicals in healthcare, the defining differences from traditional pharmaceuticals and generics, and the regulatory processes for managing these health products. There is a focus on post-market activities which serve as the main guard for ensuring the safe use of these innovations.

Due to the limited availability of seats, early registration is strongly recommended.    


 Click here for a step by step guide on how to register.

about singapore


Date and Time

02 Nov 2020 @ 09:00 - 06 Nov 2020 @ 18:00